World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
82364
World Ranking
5043
National Ranking
2731

Overview

Arthur Kavanaugh is affiliated with the University of California, San Diego in the United States. Their primary research spans the fields of Medicine and Immunology and Microbiology, with a significant focus on Rheumatology, Immunology, Hematology, Genetics, and Pathology and Forensic Medicine.

The research topics that Kavanaugh has most frequently addressed include:

  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • Chronic Lymphocytic Leukemia Research
  • Dermatology and Skin Diseases
  • Fibromyalgia and Chronic Fatigue Syndrome Research

Kavanaugh has published extensively in several venues, with the most frequent publication outlets being:

  • Annals of the Rheumatic Diseases
  • The Journal of Rheumatology
  • ACR Open Rheumatology
  • Arthritis Research & Therapy
  • Arthritis & Rheumatology

Some of Kavanaugh's recent papers include:

  • "2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases" (2020, Arthritis & Rheumatology)
  • "Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021" (2022, Nature Reviews Rheumatology)
  • "Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies" (2020, Journal of the American Academy of Dermatology)
  • "Psoriatic arthritis" (2021, Nature Reviews Disease Primers)
  • "Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial" (2020, The Lancet)

Kavanaugh has collaborated frequently with a set of co-authors, among them:

  • Philip J. Mease, with 41 joint publications
  • Dafna D. Gladman, with 27 joint publications
  • Laura C. Coates, with 23 joint publications
  • Alexis Ogdie, with 21 joint publications
  • Enrique R. Soriano, with 16 joint publications

Best Publications

  • 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

    Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

    Ferdinand C Breedveld;Michael H Weisman;Arthur F Kavanaugh;Stanley B Cohen

  • 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

    Jasvinder A. Singh;Daniel E. Furst;Aseem Bharat;Jeffrey R. Curtis

  • Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial

    Edward C. Keystone;Arthur F. Kavanaugh;John T. Sharp;Hyman Tannenbaum

  • The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.

    Paul Emery;Roy Fleischmann;Anna Filipowicz-Sosnowska;Joy Schechtman

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: ACR RA Treatment Recommendations

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

    Iain B McInnes;Philip J Mease;Bruce Kirkham;Arthur Kavanaugh

  • Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

    C Antoni;G G Krueger;K de Vlam;C Birbara

  • Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    Iain B McInnes;Arthur Kavanaugh;Alice B Gottlieb;Lluís Puig

  • Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

    Christian E. Antoni;Arthur Kavanaugh;Bruce Kirkham;Zuhre Tutuncu

  • Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

    Christopher Ritchlin;Proton Rahman;Arthur Kavanaugh;Iain B McInnes

  • Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.

    Philip J. Mease;Iain B. McInnes;Bruce Kirkham;Arthur Kavanaugh

  • Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

    Alice Gottlieb;Alan Menter;Alan Mendelsohn;Yaung-Kaung Shen

  • Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

    Cem Gabay;Paul Emery;Ronald van Vollenhoven;Ara Dikranian

  • Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.

    Arthur Kavanaugh;Iain McInnes;Philip Mease;Gerald G. Krueger

  • Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

    Hal M. Hoffman;Martin L. Throne;N. J. Amar;Mohamed Sebai

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

Frequent Co-Authors

Philip J. Mease
Philip J. Mease University of Washington
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Iain B. McInnes
Iain B. McInnes University of Glasgow
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Paul Emery
Paul Emery University of Leeds
Philip S. Helliwell
Philip S. Helliwell University of Leeds
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Edward C. Keystone
Edward C. Keystone University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees can open doors to rewarding careers in healthcare, even if studying Medicine in the USA isn’t your chosen path. Many students are turning to remote learning for flexibility and accessibility while advancing in clinical or administrative roles.

For those interested in leadership and management, earning a master’s degree from cahme accredited online healthcare administration programs can help you qualify for top positions in hospitals and health systems. If you’re a registered nurse aiming to boost your credentials, an rn to bsn online with no clinicals program offers a convenient pathway to a bachelor’s degree without the need for on-site requirements.

Nurses interested in advanced practice and leadership roles can fast-track their education through the shortest dnp program online. Additionally, several reputable dnp programs online offer flexible coursework to accommodate busy professionals.

As healthcare continues to evolve, these online degree options provide diverse avenues for career advancement, skill-building, and increased impact in the medical field.

Best Scientists Citing Arthur Kavanaugh

Trending Scientists